Stockscreener 앱 받기
23.98
0.17%
0.04
시간 외 거래:
23.98
전일 마감가:
$23.94
열려 있는:
$24.04
하루 거래량:
429.79K
Relative Volume:
0.58
시가총액:
$1.44B
수익:
$439.00K
순이익/손실:
$-105.64M
주가수익비율:
-13.32
EPS:
-1.8
순현금흐름:
$-60.70M
1주 성능:
+5.55%
1개월 성능:
-5.96%
6개월 성능:
-23.87%
1년 성능:
-45.14%
1일 변동 폭
$23.85
$24.75
1주일 범위
$22.41
$24.75
52주 변동 폭
$21.97
$71.71
Janux Therapeutics Inc Stock (JANX) Company Profile
명칭
Janux Therapeutics Inc
전화
(858) 751-4493
주소
10955 VISTA SORRENTO PARKWAY, SAN DIEGO
JANX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
JANX
Janux Therapeutics Inc
|
23.98 | 1.44B | 439.00K | -105.64M | -60.70M | -1.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Janux Therapeutics Inc Stock (JANX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-08-19 | 개시 | Piper Sandler | Overweight |
| 2025-07-11 | 개시 | Raymond James | Outperform |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-12-03 | 재확인 | H.C. Wainwright | Buy |
| 2024-11-22 | 개시 | Leerink Partners | Outperform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-09-06 | 개시 | Stifel | Buy |
| 2024-05-30 | 개시 | Scotiabank | Sector Perform |
| 2024-03-21 | 개시 | BTIG Research | Buy |
| 2024-03-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-06 | 개시 | Wedbush | Outperform |
| 2022-11-14 | 개시 | William Blair | Outperform |
모두보기
Janux Therapeutics Inc 주식(JANX)의 최신 뉴스
Has Janux Therapeutics Inc. formed a bullish divergence2025 Investor Takeaways & Weekly Top Gainers Alerts - Newser
Is Janux Therapeutics Inc. trading at a discountExit Point & Consistent Income Trade Ideas - خودرو بانک
Why is Janux Therapeutics Inc. stock going upEarnings Performance Report & Long-Term Capital Growth Strategies - خودرو بانک
What momentum shifts mean for Janux Therapeutics Inc.July 2025 Momentum & Technical Pattern Based Signals - Newser
Key metrics from Janux Therapeutics Inc.’s quarterly dataTrend Reversal & Risk Managed Trade Strategies - Newser
Custom watchlist performance reports with Janux Therapeutics Inc.Insider Selling & Daily Market Momentum Tracking - Newser
Why Janux Therapeutics Inc. is moving todayMarket Rally & AI Enhanced Execution Alerts - Newser
How to recover losses in Janux Therapeutics Inc. stockBreakout Watch & Low Risk High Win Rate Picks - Newser
Technical signs of recovery in Janux Therapeutics Inc.July 2025 Update & High Accuracy Swing Entry Alerts - Newser
Real time breakdown of Janux Therapeutics Inc. stock performanceJobs Report & AI Driven Stock Movement Reports - Newser
Tools to assess Janux Therapeutics Inc.’s risk profileMarket Movers & Low Drawdown Momentum Trade Ideas - Newser
Is Janux Therapeutics Inc. showing signs of accumulationJuly 2025 Reactions & High Conviction Investment Ideas - Newser
How to integrate Janux Therapeutics Inc. into portfolio analysis tools2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Is Janux Therapeutics Inc. stock a value trapJuly 2025 Reactions & Weekly Watchlist for Hot Stocks - خودرو بانک
Janux Therapeutics: Guggenheim initiates Buy rating with $72 price target. - AInvest
Guggenheim Initiates Janux Therapeutics at Buy With $72 Price Target - MarketScreener
Guggenheim initiates Janux Therapeutics stock with Buy rating on PSMA therapy - Investing.com
Sentiment analysis tools applied to Janux Therapeutics Inc.2025 Pullback Review & Scalable Portfolio Growth Methods - Newser
Should you wait for a breakout in Janux Therapeutics Inc.July 2025 Drop Watch & Advanced Technical Signal Analysis - Newser
How to interpret RSI for Janux Therapeutics Inc. stock2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Will Janux Therapeutics Inc. stock recover after recent drop2025 Technical Overview & Low Drawdown Investment Strategies - Newser
Predicting Janux Therapeutics Inc. trend using moving averagesWeekly Trade Review & High Conviction Buy Zone Alerts - Newser
Strategies to average down on Janux Therapeutics Inc.Market Sentiment Review & Entry Point Confirmation Signals - Newser
Multi asset correlation models including Janux Therapeutics Inc.Portfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Can momentum traders help lift Janux Therapeutics Inc.July 2025 Market Mood & Precise Entry and Exit Recommendations - Newser
Can Janux Therapeutics Inc. disrupt its industryBond Market & Real-Time Volume Analysis Alerts - khodrobank.com
Is Janux Therapeutics Inc.’s ROIC above industry averageMarket Sentiment Summary & Consistent Profit Trading Strategies - خودرو بانک
How Janux Therapeutics Inc. stock performs during market volatilityInflation Watch & Verified Technical Signals - Newser
Risk adjusted return profile for Janux Therapeutics Inc. analyzedJuly 2025 Decliners & Capital Efficient Trade Techniques - Newser
Published on: 2025-09-02 13:17:12 - Newser
Can a trend reversal in Janux Therapeutics Inc. lead to recoveryFed Meeting & Technical Confirmation Alerts - Newser
Janux Therapeutics Inc. stock daily chart insightsWeekly Trend Summary & Fast Entry High Yield Stock Tips - Newser
Published on: 2025-09-02 03:50:49 - Newser
Tick level data insight on Janux Therapeutics Inc. volatility2025 Sector Review & Consistent Profit Trading Strategies - Newser
Can you recover from losses in Janux Therapeutics Inc.2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
How to use a screener to detect Janux Therapeutics Inc. breakoutsEarnings Recap Report & Long-Term Safe Investment Ideas - Newser
Is it too late to sell Janux Therapeutics Inc.Treasury Yields & Community Verified Trade Alerts - Newser
Published on: 2025-09-01 15:48:42 - Newser
Werewolf Therapeutics’s SWOT analysis: innovative platform drives stock potential - Investing.com
Why is Janux Therapeutics Inc. stock going downStop Loss & Reliable Volume Spike Alerts - خودرو بانک
Market Recap: Why is Janux Therapeutics Inc. stock going upWeekly Trend Report & Free Long-Term Investment Growth Plans - خودرو بانک
Janux Therapeutics Inc (JANX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Janux Therapeutics Inc 주식 (JANX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Meyer Andrew Hollman | Chief Business Officer |
May 01 '25 |
Sale |
32.03 |
3,333 |
106,745 |
82,139 |
1.40%
자본화:
|
볼륨(24시간):